| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Revenue | $607.7M | -4.2% |
| Cost of Revenue | $308.0M | -2.8% |
| Gross Profit | $299.7M | -5.7% |
| R&D Expense | $98.0M | -3.4% |
| SG&A Expense | $86.2M | -20.2% |
| Operating Income | -$652.4M | +45.3% |
| Interest Expense | $98.8M | -3.6% |
| Pre-tax Income | -$724.6M | +42.8% |
| Income Tax | $1.2M | +101.4% |
| Net Income | -$659.8M | +38.3% |
| EPS (Basic) | -$2.14 | +39.2% |
| EPS (Diluted) | -$2.14 | +39.2% |
| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $197.3M | +46.8% |
| Accounts Receivable | $133.4M | -17.4% |
| Current Assets | $379.6M | +11.8% |
| Total Assets | $2.37B | -24.5% |
| Current Liabilities | $333.4M | -1.6% |
| Long-term Debt | $1.04B | -0.6% |
| Total Liabilities | $1.49B | -4.0% |
| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $99.1M | +16.8% |
| Capital Expenditures | $25.2M | -13.8% |
| Investing Cash Flow | -$25.2M | +13.8% |
| Financing Cash Flow | -$13.0M | +7.3% |
| Free Cash Flow | $73.9M | +32.9% |
| Stockholders' Equity |
| $844.8M |
| -43.1% |